Skip to main content

Table 2 Percentage of neoadjuvant therapy performed in each time period in clinical stage UICC III patients

From: Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Neoadjuvant-Therapy in clinical stage 1993-2001 (n=142) 2002. 2010 (n=204) p-value
cUICC II/III No. % No. %
No 102 71.8 32 15.7 <0.001
Chemo 1 0.7 0 0 n.s.
Radio 29 20.4 102 50.0 <0.001
Radiochemo 10 7.0 70 34.3 <0.001